In laboratories where living tissue is coaxed into mimicking the human heart, researchers have uncovered a conversation that medicine had long overlooked. Hypertrophic cardiomyopathy — a condition that thickens the heart's walls and can end lives without warning — has long been traced to mutations in genes like MYBPC3, yet the mutation alone tells only part of the story. A team led by Nathaniel Huebsch has shown that the disease's full expression depends on a chemical dialogue between two cell types, cardiomyocytes and fibroblasts, a crosstalk that intensifies as the heart tissue stiffens and